Company / Operating Cash Flow
Solventum Operating Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$369.0M
FY2025
5-year range
$369.0M / $1.9B
FY2022-FY2025
Trend
-68.9%
vs FY2024
Sector context
#60 of 164
Health Care
What the data says
At $369M, Solventum's operating cash flow ranks #60 of 164 in the Health Care sector. Declined from $1.9B to $369M over the past 2 years.
Based on SEC 10-K filings.
$369M in FY2025 with a 3-year CAGR of -39.7%.
Declined from $1.9B to $369M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -39.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 164 in Health CareTop 37% of 164This company $369.0M Sector average $1.0B
▼
-64.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -39.7%, indicating a declining trend.
- In FY2025, operating cash flow decreased 68.9% year-over-year.
- Ranks #60 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $369.0M | -68.9% |
| FY2024 | $1.2B | -38.1% |
| FY2023 | $1.9B | +14.1% |
| FY2022 | $1.7B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026